Literature DB >> 32893473

Estimands in practice: Bridging the gap between study objectives and statistical analysis.

Alan Phillips1, Tim Clark2.   

Abstract

The International Council for Harmonisation (ICH) guideline E9 Statistical Principles for Clinical Trials (1) was issued in 1998. In October 2014, an addendum to ICH E9 was proposed on statistical principles relating to estimands and sensitivity analyses. The final version of the addendum to ICH E9 (R1) (2) was issued in November 2019. This virtual edition of Pharmaceutical Statistics takes a closer look at some of the progress that has been made since 2018 when implementing the estimand framework within clinical research. The articles discussed in this virtual issue are not new, but a compilation from previous issues. This specific article will act as a refresher for those not familiar with the topic and discuss the ABCs of estimands and their proposed deployment for improving the quality of clinical research. An overview of the more recent Pharmaceutical Statistics articles on estimands will be provided, signifying areas where progress have been made. The articles should be considered as contributions to the ongoing discussions rather than the final word. Finally, a personal perspective on the estimand success story and remaining challenges with proposed solutions will be discussed.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  ICH E9; estimands; intercurrent events

Mesh:

Year:  2020        PMID: 32893473     DOI: 10.1002/pst.2056

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  3 in total

Review 1.  Estimands: bringing clarity and focus to research questions in clinical trials.

Authors:  Timothy Peter Clark; Brennan C Kahan; Alan Phillips; Ian White; James R Carpenter
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

2.  Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands.

Authors:  Suzie Cro; Brennan C Kahan; Sunita Rehal; Anca Chis Ster; James R Carpenter; Ian R White; Victoria R Cornelius
Journal:  BMJ       Date:  2022-08-23

3.  Estimators for handling COVID-19-related intercurrent events with a hypothetical strategy.

Authors:  Florian Lasch; Lorenzo Guizzaro
Journal:  Pharm Stat       Date:  2022-06-28       Impact factor: 1.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.